Synthetic peptides derived from the Wilms' tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cells

Ludmila Müller(Max Planck Institute for Human Development), Graham Pawelec(Health Sciences North), Ashley Knights(University of Tübingen)
The Hematology Journal
January 1, 2003
Cited by 25


Related Papers